Adia Nutrition Inc. Celebrates Adia Med's Approval as a UnitedHealthcare Provider in $5.3 Trillion Healthcare Market
Winter Park, Florida--(Newsfile Corp. - August 6, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its healthcare clinic, Adia Med, has been officially approved as a provider with UnitedHealthcare, effective as of August 1, 2025. This significant milestone positions Adia Med within the $5.3 trillion U.S. healthcare market [CMS National Health Expenditure Projections, 2024-2033], enabling the clinic to expand access to its innovative regenerative medicine treatments fo
Healthcare and Hospitals, Health
2025-08-06 11:43 AM EDT | Adia Nutrition Inc.
Cosmo Pharmaceuticals Confirms No Exposure to Proposed U.S. Tariffs and Reaffirms Growth Momentum
Dublin, Ireland--(Newsfile Corp. - August 6, 2025) - Cosmo Pharmaceuticals N.V. (“Cosmo”) notes the recent market volatility following reports on potential U.S. tariffs on Swiss pharmaceutical companies. Cosmo confirms that its operations and revenue streams are not impacted by any potential U.S. tariff measures, as the Company does not export products from Switzerland to the United States and operates on long-term contracts with global partners.
Healthcare and Hospitals, Health
2025-08-06 11:11 AM EDT | Cosmo Pharmaceuticals N.V.
Kovo+ Holdings Inc. Announces Non-Brokered Private Placement
Calgary, Alberta--(Newsfile Corp. - August 6, 2025) - Kovo+ Holdings Inc. (TSXV: KOVO) ("Kovo" or the "Company") is pleased to announce an offering of up to 827,820,000 units (each, a "Unit") on a non-brokered private placement basis for gross proceeds of up to approximately $41,391,000 (USD$30,000,000) (the "Offering") at a price of $0.05 per Unit. Each Unit will consist of (i) one common share of the Company and (ii) one-half of one non-transferable common share
Technology, Healthcare and Hospitals, Internet Technology
2025-08-06 9:04 AM EDT | Kovo+ Holdings Inc.
Adia Med Enters $1.9 Billion Glutathione Industry with Innovative IV and Transdermal Therapies, Expanding High-Demand Offerings
Winter Park, Florida--(Newsfile Corp. - August 6, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a rising leader in regenerative medicine, is excited to announce that its subsidiary, Adia Med, is now incorporating glutathione IV therapies into select treatment protocols at its state-of-the-art clinics. In a complementary move, Adia Labs has introduced Glutaryl Transdermal Glutathione Spray, an innovative product leveraging the antioxidant properties of glutathione, often referred to as the body'
Healthcare and Hospitals, Health
2025-08-06 9:00 AM EDT | Adia Nutrition Inc.
HEALWELL AI to Announce Fiscal Second Quarter 2025 Financial Results on August 13, 2025
Toronto, Ontario--(Newsfile Corp. - August 6, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the Company will release its Fiscal Second Quarter 2025 financial results for t
Technology, Healthcare and Hospitals
2025-08-06 3:15 AM EDT | HEALWELL AI
Medexus Schedules First Fiscal Quarter 2026 Conference Call
Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Wednesday, August 13, 2025 to discuss Medexus's results for its first fiscal quarter ended June 30, 2025. Medexus expects to file its financial statements and MD&A after markets close on August 12, 2025. To participate in the call, please dial the following numbers:
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-08-05 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Discovery Senior Living Unveils Calligraphy, a New Era of Distinguished Senior Living Begins
Bonita Springs, Florida--(Newsfile Corp. - August 5, 2025) - Discovery Senior Living ("Discovery" or the "Company"), one of the nation's largest most trusted and forward-thinking senior housing operators, proudly announces the launch of its newest innovation, Calligraphy, a premier brand of distinguished senior living communities redefining excellence for the next generation of older adults. Rethinking. Reimagining. Redefining. Welcome to the Calligraphy Era - The Art of Se
Healthcare and Hospitals, Real Estate, Housing
2025-08-05 2:01 PM EDT | Discovery Senior Living
BioMark Diagnostics Announces Expansion of Its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International Partnerships
Vancouver, British Columbia--(Newsfile Corp. - August 5, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early cancer detection, announces today the completion of a strategic laboratory equipment leasing agreement, substantially doubling BioMark's testing capacity and positioning the Company for the imminent commercial launch of its lung cancer assay. This critical advancement in its operational capabi
Technology, Biotechnology, Healthcare and Hospitals
2025-08-05 8:30 AM EDT | BioMark Diagnostics, Inc.
GRAFAPEX (treosulfan) for Injection Receives CMS Approval of New Technology Add-On Payment (NTAP) for Eligible Cases in CMS's Fiscal Year 2026
Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the US Centers for Medicare & Medicaid Services (CMS) has approved New Technology Add-On Payment (NTAP) reimbursement for eligible cases involving the use of GRAFAPEX™ (treosulfan) for Injection for CMS's fiscal year 2026, which runs from October 1, 2025 to September 30, 2026.* The NTAP program is designed to provide temporar
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-08-05 7:00 AM EDT | Medexus Pharmaceuticals Inc.